BlackRock Investment Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

BlackRock Investment Management’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$4.15M	Sell	184,753 -548	-0.3%	-$10.7K	﹤0.01%	1721
2016 Q3	$4.21M	Sell	185,301 -38	-0%	-$892	0.01%	1605
2016 Q2	$4.37M	Buy	185,339 +12,293	+7%	+$304K	0.01%	1535
2016 Q1	$3.53M	Buy	173,046 +7,299	+4%	+$232K	﹤0.01%	1610
2015 Q4	$8.53M	Buy	165,747 +11,942	+8%	+$579K	0.01%	1039
2015 Q3	$6.55M	Sell	153,805 -2,623	-2%	-$127K	0.01%	1183
2015 Q2	$7.13M	Buy	156,428 +30,087	+24%	+$1.21M	0.01%	1224
2015 Q1	$4.8M	Buy	126,341 +10,354	+9%	+$356K	0.01%	1393
2014 Q4	$3.29M	Buy	115,987 +15,321	+15%	+$426K	﹤0.01%	1680
2014 Q3	$2.54M	Buy	100,666 +286	+0.3%	+$7.53K	﹤0.01%	1822
2014 Q2	$2.93M	Buy	100,380 +69,868	+229%	+$1.69M	﹤0.01%	1785
2014 Q1	$790K	Buy	30,512 +566	+2%	+$15.1K	﹤0.01%	2682
2013 Q4	$771K	Buy	29,946 +2,449	+9%	+$59.5K	﹤0.01%	2697
2013 Q3	$736K	Buy	27,497 +2,340	+9%	+$55.7K	﹤0.01%	2663
2013 Q2	$618K	Buy	+25,157	New	+$500K	﹤0.01%	2712

Other funds holding PTLA

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock Investment Management's PTLA Position: Q4 2016 in Review

BlackRock Investment Management reduced its Portola Pharmaceuticals, Inc. (PTLA) stake by 0.3% in Q4 2016, selling an estimated $10.7K and leaving 184,753 shares worth $4.15M. The position accounts for ﹤0.01% of the portfolio, ranked #1721.

BlackRock Investment Management first reported a position in PTLA in Q2 2013 and has held it in 15 quarters since. The position peaked at $8.53M in Q4 2015. 150 funds tracked by Wall St. Rank hold PTLA as of Q4 2016.

BlackRock Investment Management held 184,753 shares of Portola Pharmaceuticals, Inc. worth $4.15M as of Q4 2016.
BlackRock Investment Management sold 548 Portola Pharmaceuticals, Inc. shares in Q4 2016, an estimated $10.7K.
Portola Pharmaceuticals, Inc. made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #1721 holding.
BlackRock Investment Management first reported a position in Portola Pharmaceuticals, Inc. in Q2 2013 and has held it in 15 quarters since.
BlackRock Investment Management's Portola Pharmaceuticals, Inc. position peaked at $8.53M in Q4 2015.
150 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.